Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

26Cr 30Cr 42Cr 47Cr 44Cr

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 17Cr

APAC

- - 12Cr 21Cr 17Cr

Americas

- - 8.6Cr 7.27Cr 9.88Cr

Sweden

2.17Cr 86.66L - - 85.69L

South and Latin America

7L 7L - - -

Dach (Germany, Austria, Switzerland)

4.06Cr 3.19Cr - - -

The Rest of The Nordic Countries

53.71L 1.21Cr - - -

EMEA

- - 22Cr 19Cr -

France

1.39Cr 1.53Cr - - -

ROE (Other Europe)

4.63Cr 7.8Cr - - -

Asia

8.21Cr 8.4Cr - - -

USA

5.06Cr 7.08Cr - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 02/02/2026
Chief Executive Officer 49 21/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 50 -
Corporate Officer/Principal 52 01/04/2026

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 01/01/2017
Director/Board Member 60 07/05/2021
Chairman 61 05/05/2023
Director/Board Member 60 05/05/2023
Director/Board Member 66 05/05/2023
Director/Board Member 55 23/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
39,24,969 11.93 % 13 M kr
9.926 %
32,66,170 9.926 % 11 M kr
Cervantes Capital AB
9.521 %
31,32,758 9.521 % 10 M kr
5.197 %
17,10,018 5.197 % 6 M kr
4.863 %
16,00,000 4.863 % 5 M kr
NameStocks%Valuation
44.01 %
3,79,762 44.01 % 1 M kr
30.49 %
2,63,125 30.49 % 880 721 kr
Cervantes Capital AB
13.91 %
1,20,000 13.91 % 401 659 kr
Svea Bank AB
11.59 %
1,00,000 11.59 % 334 716 kr

Holdings: C-Rad AB

NameStocks%Valuation
7,85,5002.39% 3 M $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.com
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
-.--%+10.48%-30.12%-33.14% 7.97Cr
-1.72%+3.44%+22.84%+56.71% 26TCr
-2.00%+0.75%+7.82%+20.94% 16TCr
-3.73%-4.48%-19.14%+64.75% 15TCr
-1.66%-8.12%-58.32%-17.99% 6.08TCr
-.--%+2.46%-11.69%-7.41% 5.33TCr
-2.57%+3.30%+11.59%+44.40% 5.3TCr
+0.84%-3.12%+7.47%+62.40% 5.07TCr
-3.47%+1.04%+19.48%+69.17% 4.93TCr
-3.61%+1.99%+32.36%+93.99% 4.55TCr
Average -1.79%+0.77%-1.77%+35.38% 8.84TCr
Weighted average by Cap. -2.10%+0.15%+4.03%+44.65%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - C-Rad AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
23.20SEK
Average target price
35.00SEK
Spread / Average Target
+50.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - C-Rad AB